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ABSTRACT
Introduction: Cardiac tamponade (CT) is a
life-threatening complication of
radiofrequency ablation (RFA). The course and
outcome of CT in low-to-medium volume
electrophysiology centers are underreported.
Methods: We analyzed the incidence,
management and outcomes of CT in 1500
consecutive RFAs performed in our center
during 2011–2016.
Results: Of 1500 RFAs performed in 1352
patients (age 55 years, interquartile range:
41–63), 569 were left-sided procedures (n = 406
with transseptal access). Conventional RFA or
irrigated RFA was performed in 40.9% and
59.1% of procedures, respectively. Ablation
was performed mostly for atrioventricular
nodal reentrant tachycardia (25.4%), atrial
fibrillation (AF; 18.5%), atrial flutter (18.4%),
accessory pathway (16.5%) or idiopathic
ventricular arrhythmia (VA; 12.3%), and rarely
for structural VA (2.1%). CT occurred in 12
procedures (0.8%): 10 AF ablations, 1 idiopathic
VA and 1 typical atrial flutter ablation. Factors
significantly associated with CT were older age,
pre-procedural oral anticoagulation, left-sided
procedures, transseptal access, AF ablation,
irrigated RFA and longer fluoroscopy time (on
univariate analysis), and AF ablation (on
multivariable analysis). The perforation site
was located in the left atrium (n = 7), right
atrium (n = 3), or in the left ventricle or
coronary sinus (n = 1 each). Upon
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pericardiocentesis, two patients underwent
urgent cardiac surgery because of continued
bleeding. There was no fatal outcome. During
the follow-up of 19 ± 14 months, eight patients
were arrhythmia free.
Conclusion: Incidence of RFA-related CT in our
medium-volume center was low and
significantly associated with AF ablation. The
outcome of CT was mostly favorable after
pericardiocentesis, but readily accessible
cardiothoracic surgery back-up should be
mandatory in RFA centers.
Keywords: Atrial fibrillation; Cardiac
perforation; Cardiac tamponade; Cardiology;
Catheter ablation; Outcomes;
Procedure-related complications
INTRODUCTION
Electrophysiology (EP) development has been
accompanied by an exponential increase in the
number of catheter ablation (CA) procedures
[1]. Although the CA success rates have
improved, the rate of complications has
remained unchanged, probably because of an
increase in the number of complex procedures
[1, 2].
Cardiac perforation with tamponade is the
most frequent potentially fatal complication of
CA, with the incidence of 0.2–6% [3, 4]. Death
and pericardiocentesis-related complications
are twice higher with tamponades occurring
during cardiac interventional procedures than
with tamponade caused by other factors [5].
Additionally, the CA procedure discontinuation
due to tamponade is often clinically frustrating,
as it usually implies the need to repeat the
procedure, which carries an additional
psychological burden for both the patient and
operator. The prevention of CA-related
tamponade, its early detection and prompt
management are of critical importance for the
patient’s outcome [5–8].
The number of reports on the management
and outcomes of tamponade resulting from EP
procedures is limited, and published data are
mostly pertinent to high-volume academic
centers, while reports from medium and small
centers are scarce [1, 2, 6–8]. Given that
low-to-medium-volume centers are the only
available for CA of cardiac arrhythmias for
many cardiology practices in all parts of the
world, the data from a medium-volume center
would be of interest for many general
cardiologists when discussing CA with their
patients. In this article, we describe the
incidence, management and outcomes of
CA-related cardiac perforation in a set of 1500
consecutive CA procedures performed in a
single, medium-volume center over a 5-year
period.
METHODS
We analyzed consecutive radiofrequency (RF)
CA procedures performed between June 2011
and January 2016 in the Clinical Centre of
Serbia. We retrospectively analyzed the data
prospectively collected within the hospital EP
laboratory electronic database and patient
medical records. Before the ablation procedure,
written informed consent was obtained in all
patients. The study was conducted in
accordance with the Declaration of Helsinki of
1964 as revised in 2013. The study protocol was
approved by the Institutional Review Board of
our hospital.
Ablation Procedure
Via the right femoral vein, three multipolar
catheters were inserted into the distal coronary
sinus (CS), right atrium (RA) and right ventricle
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(RV). During all of the procedures noninvasive
measurement of arterial blood pressure was
performed every 5 min along with continuous
noninvasive pulse oximetry.
Left-Sided Procedures
Transseptal puncture (TSP) was carried out with
a long needle and sheath (BRK1/BRK1-XS,
Swartz SL0/SL1, Daig Corp., Minnetonka, MN,
USA) under fluoroscopy in two orthogonal (the
right and left anterior oblique 45) projections
and using only a CS catheter as an anatomical
landmark, as reported previously [9].
Transesophageal (TEE) or intracardiac
echocardiograms (ICE) were performed if
needed, at the discretion of the operator. The
right femoral artery was used for the transaortic
approach. Ablation of left-sided accessory
pathways (APs) and left-sided ventricular
arrhythmias (VAs) was performed with the
transseptal and/or transaortic approach,
depending on the operator’s preference.
RF Ablation
Ablation of supraventricular tachycardia and
idiopathic VAs was performed using solid 4-mm
conventional-tip catheters (RF Marinr,
Medtronic, USA) or 3.5 to 4-mm externally
irrigated-tip catheters (CoolPath or CoolFlex, St
Jude, USA, or ThermoCool Biosense-Webster,
USA), depending the operator’s preference,
while ablation of atrial flutter (AFL), atrial
tachycardia (AT), atrial fibrillation (AF), and
structural ventricular tachycardia (VT) was
exclusively performed with irrigated RF
technology. Ablation was performed in the
temperature mode. For conventional ablations
the setup was 55–65 C and 30–50 W, while in
irrigated RF ablations, it was 43 C and 30–40 W
with a flow rate of 17–30 ml/min. RF
application was promptly terminated in the
case of any increase in impedance or its decrease
by [10 X. The navigation mapping system
(Velocity, St Jude or CARTO3
Biosense-Webster, USA) was used in all AF or
structural VT ablations and in some AT and
idiopathic VA ablations.
AF Ablation
The venous approach with three catheters was
applied, one of which was inserted into the
distal CS, for stimulation and electroanatomical
reference. A single TSP was used, inserting two
long sheaths through the same puncture site
into the left atrium (LA). Navigation of the
ablation catheter was performed with a long
steerable sheath (8.5-Fr Agilis NXT, St Jude
Medical, MN, USA), and pulmonary vein (PV)
activity was evaluated with a circular 10- to
20-polar catheter navigated by a long
non-steerable sheath (Swartz SL0 or SL1). After
selective PV angiography, a 3D LA map was
created, and fusion with the computed
tomographic image was performed. In all
patients with AF paroxysms lasting \48 h,
only circumferential antral PV isolation was
performed. The setup was 43 C and 30 W. RF
applications on the anterior and posterior wall
lasted 40–60 s and 20–40 s, respectively. In the
sites with PV activation sequence change, delay
or isolation, RF application was prolonged to
90–120 s. In patients with prolonged AF
episodes ([48 h), additional substrate ablation
was performed. The complex atrial electrograms
were visually identified, and their ablation was
performed until local potential elimination was
achieved. Endocardial LA roof and mitral
isthmus ablation was performed using 30 W,
with the applications lasting 60–120 s in the
same location, up to the linear block or
maximum 30 min of RF per line. Epicardial
mitral isthmus ablation in the distal CS was
performed with RF pulses of 18–25 W lasting
40–120 s cumulatively up to 8 min.
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Anticoagulation
Unfractionated heparin was administered
intravenously during persistent AFL/AT
ablation and in all left-sided procedures (bolus
of 50–100 i.u./kg). In all patients receiving oral
anticoagulant therapy, the strategy of
interrupted warfarin or a non-vitamin K
antagonist oral anticoagulant (NOAC) and
bridging with subcutaneous enoxaparin
(0.5 mg/kg, twice a day) was applied. The
procedure was performed when the
international normalized ratio (INR) was below
1.5. In patients taking antiplatelet therapy,
ablation was performed without interrupting
aspirin therapy, but not in case of dual
antiplatelet therapy. During AF ablation,
unfractionated heparin was administered
immediately after TSP, with the maintenance
of activated clotting time (ACT) in the
280–350 s range. Four hours after hemostasis,
enoxaparin was reintroduced, which was also
done the following day with the oral
anticoagulant, with bridging until INR reached
a value C2.
Pericardiocentesis
In case of systolic arterial pressure dropping
below 90 mmHg and/or movement loss in the
left margin of the cardiac silhouette during
fluoroscopy, an echocardiogram was performed
immediately (Fig. 1a, b). After the tamponade
confirmation, intravenous fluid infusion and
inotropic support were started. If the patient
had received heparin, 50 mg of protamine was
administered intravenously.
The fluoroscopically guided subxiphoid
approach was applied for pericardiocentesis in
the left lateral projection [11]. The skin was
punctured 2 cm below the xiphoid process with
a needle positioned on a contrast-filled syringe
and directed toward the left shoulder.
Intermittent injection of the contrast dye was
used to confirm the progress of the needle
through the tissue. Upon entering the
pericardial space, 30–50 ml of blood was
drawn out, and 20 ml of contrast dye was
injected (Fig. 1c, d). Next, a long J-shaped
guidewire was introduced through the needle
into the pericardial cavity, a 6- or 8-Fr pigtail
drainage catheter was positioned over the wire
into the pericardial sac, and blood removal was
continued. In case of continuous bleeding,
direct auto-transfusion of the drained blood
via a femoral venous sheath and/or allogeneic
transfusion was performed, and the
cardiothoracic surgical team was alerted. If
definite hemodynamic stability was achieved
using pericardiocentesis, 120 mg of gentamicin
and 100 mg of methylprednisolone were
injected via the drainage catheter into the
pericardial cavity, and the patient was
transferred to the Intensive Care Unit.
Enoxaparin was restarted when the volume of
the drained fluid fell below 20 ml in 4 h, while
the oral anticoagulant was restarted after
drainage catheter removal, usually 12–48 h
upon pericardiocentesis.
Study Outcomes
The principal study outcome was cardiac
perforation during CA. The perforation site
was determined either directly during the
surgical procedure or in other patients was
assumed on the basis of the following: (1)
catheter movement outside the cardiac
silhouette during fluoroscopy; (2) loss of
pace capture from the catheter tip; (3)
audible ‘‘steam-pops’’ and/or sudden
impedance increase during RF; (4) sudden
hypotension after RF application; (5) contrast
dye retention in the pericardium after a TSP
attempt [8].
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Statistical Analysis
Continuous variables are presented as mean (±1
standard deviation) or median [with the
interquartile range (IQR)], while categorical
variables are summarized as percentages. The
association of clinical parameters and
procedure-related variables presented in
Table 2 with the occurrence and outcome of
tamponade was analyzed using univariate and
multivariable binary logistic regression
methods. A two-sided P value of \0.05 was
considered statistically significant. Analyses
were performed using the SPSS software,
version 18.0 (IBM Corp., Armonk, NY, USA).
RESULTS
During the study period, 1500 consecutive
RF-CA procedures were performed in 1352
patients (224 were redo procedures). The
median patient age was 55 years (IQR:
41–63 years), 58.1% were male, and 2.3% of all
procedures were pediatric (i.e., performed in
patients\18 years old). The distribution of CA
procedure types is presented in Table 1. A total
Fig. 1 Echocardiographic subxiphoid images (a, b) and
left lateral fluoroscopic images (c, d) of pericardial effusion
leading to cardiac tamponade, before and after
pericardiocentesis, respectively. LV left ventricle, PE
pericardial effusion, RA right atrium, RV right ventricle
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of 569 (37.9%) left-sided procedures were
performed. In 163 (28.6%) of the left-sided
procedures we used transaortic access, while
transseptal access was performed in 406 (71.4%)
procedures (the foramen ovale appertum was
used in 41, while fluoroscopy-, TEE- or
ICE-guided TSP was performed in 339, 24 and
2 procedures, respectively). Conventional RF or
irrigated RF was used in 40.9% and 59.1% of the
procedures, respectively.
There were no procedure-related deaths.
Tamponade occurred during 12 (0.8%)
procedures, of which 10 were AF ablations (9
paroxysmal and 1 persistent AF ablation), 1 was
idiopathic left-sided VA ablation, and 1
procedure was a typical AFL ablation. The
prevalence of tamponade by the procedure
type was 3.6% for AF ablation, 0.5% for VA
ablation and 0.1% for SVT (non-AF) ablation. In
11 cases tamponade occurred in the index
procedure and in 1 case during the redo
procedure, and it never re-occurred in the
same patient. On univariate analysis, the
occurrence of tamponade was significantly
more frequent in older patients, pre-procedure
oral anticoagulation, left-sided procedures,
Table 1 Baseline demographic characteristics
Characteristics Total number
of procedures
(n5 1500)
Number of patients, n 1352
Age (years) 55.0 (41.0–63.0)
Age\18 years 34 (2.3)
Males 872 (58.1)
BMI (kg/m2) 26.6 (24.6–29.8)
Heart failure 238 (15.9)
Left ventricular EF (%) 61.0 (56.0–66.0)
LA diameter (mm) 38.0 (34.0–43.0)
Coronary artery disease 174 (11.6)
Valvular heart disease 37 (2.5)
Hypertension 509 (33.9)
Diabetes mellitus 111 (7.4)
Oral anticoagulation before procedure 458 (30.5)
Number of antiarrhythmic drugs 2.0 (1.0–2.0)
Redo procedure 244 (16.3)
SVT (non-AF) 1007 (67.1)
AVNRT 381 (25.4)
Typical atrial flutter 276 (18.4)
Accessory pathway 248 (16.5)
Atrial tachycardia 56 (3.7)
AV junction 46 (3.1)
AF 277 (18.5)
Paroxysmal AF 208 (75.1)
Persistent AF 69 (24.9)
PVI only 164 (59.2)
PVI ? LA linear ablation 76 (27.4)
Stepwise ablation 37 (13.4)
VA 216 (14.4)
Idiopathic VA 184 (12.3)
Table 1 continued
Characteristics Total number
of procedures
(n5 1500)
Structural VT 32 (2.1)
Data presented as median value (interquartile range) or
numbers (percentage), unless otherwise stated
AF atrial fibrillation, AV atrioventricular, AVNRT
atrioventricular nodal reentrant tachycardia, BMI body
mass index, EF ejection fraction, LA left atrium, PVI
pulmonary vein isolation, SVT supraventricular
tachycardia, VA ventricular arrhythmia, VT ventricular
tachycardia
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transseptal procedures, AF ablation, prolonged
fluoroscopy, and irrigated-tip RF-CAs (Table 2).
On multivariable analysis, only AF ablation
(odds ratio: 13.86, 95% confidence interval:
2.78–69.04; P = 0.001) was significantly
associated with tamponade.
Table 2 Predictors of cardiac tamponade
Predictors Procedures without
tamponade
(n5 1488)
Procedures with
tamponade
(n5 12)
Univariate analysis Multivariable analysis
OR (95% CI) P value OR (95% CI) P value
Age (years) 55.0 (41.0–63.0) 63.0 (60.3–64.8) 1.05 (1.00–1.10) 0.035 – –
Males 865 (58.1) 7 (58.3) 1.01 (0.32–3.19) 0.989 – –
Oral
anticoagulation
before
procedure
447 (30.0) 11 (91.7) 25.62 (3.30–119.02) 0.002 – –
Left ventricular
EF (%)
60.0 (56.0–66.0) 63.5 (61.0–66.5) 1.00 (0.99–1.02) 0.546 – –
Left atrial
diameter (mm)
38.0 (34.0–43.0) 40.0 (36.5–44.5) 1.02 (0.95–1.10) 0.543 – –
Redo procedures 243 (16.3) 1 (8.3) 0.47 (0.07–3.03) 0.430 – –
Transseptal
procedures
396 (26.6) 10 (83.3) 13.79 (3.01–63.20) 0.001 – –
Left-sided
procedures
558 (37.5) 11 (91.7) 18.33 (2.36–142.38) 0.005 – –
AF ablation 267 (17.9) 10 (83.3) 22.87 (4.98–104.96) \0.001 13.86
(2.78–69.04)
0.001
SVT (non-AF)
ablation
1006 (67.6) 1 (8.3) 0.04 (0.01–0.34) 0.003 – –
VA ablation 215 (14.4) 1 (8.3) 0.54 (0.07–4.19) 0.554 – –
RF pulses (n) 17 (8–33) 44 (23–55) 1.01 (1.00–1.03) 0.074 – –
RF time (min) 15.5 (8.2–34.4) 52.1 (19.3–64.7) 1.01 (1.00–1.03) 0.106 – –
Energy
(91000 W)
28.0 (14.7–58.5) 77.6 (27.5–97.0) 1.01 (1.00–1.02) 0.248 – –
Irrigated-tip
catheter
875 (58.8) 12 (100) 7.71 (1.00–59.85) 0.051 – –
Fluoroscopy time
(min)
14.5 (8.1–26.5) 30.0 (17.0–39.0) 1.03 (1.00–1.06) 0.032 – –
Data shown as median (interquartile range) or numbers (percentage)
AF atrial fibrillation, EF ejection fraction, OR odds ratio, RF radiofrequency, SVT supraventricular tachycardia; VA
ventricular arrhythmia
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Management and Outcome of Tamponade
The perforation was attributed to catheter
manipulation, excessive RF ablation and
misguided TSP in five, five and two
procedures, respectively. The perforation site
was identified in the LA in seven, in the RA in
three, in the left ventricle (LV) in one and in the
CS in one procedure (Table 3).
In two cases, tamponade resulted in
electromechanical dissociation and
cardiorespiratory arrest (procedures 9 and 12;
Table 3), while in the remaining ten patients
tamponade was associated with significant
hypotension (the mean systolic blood pressure
at the moment of pericardial puncture was
59 ± 18 mmHg). Pericardiocentesis was
performed with the subxiphoid approach in 11
and with the transcardial approach in 1 patient
(Table 4). Namely, in procedure 5, the LA roof
was perforated with an ablative catheter during
an attempted right superior PV angiography.
The long steerable sheath (8.5 Fr) was left in the
pericardial space for drainage purposes, while at
the same time the re-isolation of lower PVs was
completed and protamine was administered.
The long sheath was replaced via the guidewire
with an angiographic catheter of smaller
diameter (5 Fr), and finally the guidewire itself
was left in the pericardium for an approximate
30-min observation period before final removal
after fluid accumulation cessation.
After pericardiocentesis, in ten patients
(83.3%), complete hemodynamic stability was
achieved and the drainage catheter was
removed after 6–48 h, while in two patients
(16.7%) urgent surgery was necessary because of
continuous bleeding.
In procedure 9 (Tables 3, 4), lateral PV
isolation was complicated by the posterior LA
wall perforation. After resuscitation and
pericardiocentesis, the patient experienced
painful abdomen distension with the
sonographic image showing fluid collections
in the abdominal cavity. To investigate
suspected hollow organ perforation,
emergency surgical abdomen exploration was
performed, followed by thoracotomy with
direct pericardial sac revision and fibrin glue
application around the lateral PVs because of
intraoperative suspicion of mediastinal
bleeding. After 2 weeks of post-reanimation
coma, the patient was treated for sepsis and
finally recovered.
In procedure 12 (Tables 3, 4), tamponade
occurred during the LA linear endocardial
ablation. Temporary hemodynamic recovery
was achieved with pericardiocentesis; however,
electromechanical dissociation developed
quickly, and active drainage of the
pericardium was continued during
transportation to the cardiac surgery unit
(2830 ml of blood was returned by
auto-transfusion). Subsequently, INR
spontaneously increased from 1.4 before
ablation to 2.7 prior to surgery. The patient
fully recovered after surgical mitral isthmus
suture.
Overall, the mean amount of drained blood
was 782 ± 696 ml. Nine patients received blood
transfusions (4 patients received only
auto-transfusion, 2 were given only allogeneic
transfusion, and 3 received both types of
transfusion). The mean drop in hemoglobin
after the procedure was 22 ± 14 g/l.
Pericardiocentesis-related complications
occurred in four (33.3%) patients (two cases of
clinically relevant pericarditis and two cases of
septicemia). After pericardiocentesis, most
patients were treated with anti-inflammatory
drugs for chest pain (Table 4).
In six patients (50.0%) with tamponade, the
ablation was completed despite cardiac
perforation. Redo ablation was subsequently
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performed in three patients 4, 6 and 8 months
after the complication, respectively. During
follow-up of 19 ± 14 months after ablation,
eight (66.7%) patients were arrhythmia free
and nine patients (77%) were on
antiarrhythmic drugs (Table 4).
DISCUSSION
Our study of 1500 consecutive CA procedures
performed in a medium-volume center
considers a large data set outside the
high-volume centers, showing relatively low
overall incidence of CA-related tamponade
(0.8%), with no case fatality. Similar to the
reports from high-volume centers,
periprocedural tamponade in our center most
commonly occurred with AF ablation (3.6%)
[1, 2, 4, 6, 7].
Risk Factors for Tamponade
In our center, tamponade due to RF-CA was
significantly more frequent in older patients,
with pre-procedural oral anticoagulation, with a
transseptal procedure, left-sided or AF ablation,
with the use of irrigated-tip catheters and
during the procedures with prolonged
fluoroscopy. The only multivariable predictor
of tamponade was AF ablation. Other reports
additionally described VA ablation, female sex
and the operator’s (in)experience as the risk
factor for RF-CA major complications [2, 6, 12].
Specific risks of tamponade during AF ablation
are: redo procedure, linear LA ablation and use
of RF power[45 W [4, 12, 13].
The presumed mechanisms of perforation in
our study were mechanical catheter
manipulation, excessive tissue ablation and
misdirected TSP. The use of a long steerable
sheath improves catheter stability and ablation
efficiency, but also enhances the catheter
contact force to the tissue, increasing the risk
of perforation [14]. The application of
contemporary contact force measurement
technology may reduce the perforation rate
during RFCA [15].
TSP guided only by fluoroscopy is
complicated by tamponade in 0.1–3.2% of
cases [5, 10]. ICE and TEE provide direct
visualization of the septum and offer a safer
TSP, especially in atypical anatomy, a resistant/
elastic septum and inexperienced operators
[16, 17]. Use of ICE during the AF ablation can
provide many other potential benefits, such as
the detection of LA thrombus or spontaneous
echo-contrast formation, monitoring of
catheter position and catheter-tissue contact,
early identification of pericardial effusion
during ablation, optimal RF energy titration
and reduction of radiation exposure time
[17–19]. However, routine application of TEE
requires general anesthesia in many patients
and may contribute to esophageal injury during
AF ablation [20], while use of ICE increases the
cost of the procedure [21].
More intensive anticoagulation and higher
intracavital pressure increase the risk of
tamponade during left-sided procedures [5].
Therefore, it is not surprising that in our study
the majority of tamponade cases occurred as a
complication of a left-sided AF ablation.
Tamponade is the most frequent cause of
fatal AF ablation outcome and is responsible for
a quarter of all procedure-related deaths [3]. It
has been shown that AF ablation carries a
significantly higher risk of perforation
compared with other transseptal procedures,
such as left-sided AP ablation or balloon mitral
valvuloplasty [22]. Dual transseptal access,
prolonged LA catheter manipulation time, a
thin LA wall, necessity of transmural and
extensive ablation as well as irrigated-tip
catheter use may explain a higher tamponade
1792 Adv Ther (2016) 33:1782–1796
rate in AF ablation in comparison to other types
of procedures in the present study. In
comparison to RF conventional-tip catheters,
externally irrigated-tip catheters create a deeper
and wider lesion and increase the risk of tissue
overheating and ‘‘steam-pop’’ [4, 13].
Perforation Predilection Sites
Thinned LA wall segments (the appendage,
vestibular part of the mitral annulus, posterior
roof), the RV apex and distal CS represent
perforation predilection sites during EP
procedures [5, 7, 23].
In a study of 15 patients with AF
ablation-related tamponade, the LA was
perforated in nine, the RV in five and the RA
in one patient [7]. Likewise, in our study, the LA
perforation most frequently occurred during AF
ablation (in 7 out of 10 patients with AF and
tamponade). As opposed to other studies, there
were no RV perforations in the present study,
most probably because of the simplified
catheter setup during AF ablation as well as
the absence of a RV stimulating catheter. In our
study, one procedure of typical AFL ablation led
to RA perforation. Although the cavo-tricuspid
isthmus ablation is one of the safest procedures,
this complication has also been recognized by
other authors [4].
Aggressive irrigated RF ablation, systemic
anticoagulation and higher intracavital
pressure are responsible for a significant risk of
tamponade accompanying VA ablation [2, 8].
Additionally, the differences in the wall
thickness are responsible for more frequent
perforation of the RV as compared to the LV
[5]. In a series of 892 patients subjected to RFCA
of VA, tamponade complicated 11 procedures
(1.23%) [8]. The laceration site was localized in
the RV in seven, in the LV in only one and in
three patients it remained undetermined. In the
present study, there was only one tamponade
due to VA ablation, this being an idiopathic VA
in the LV basal inferior wall segment. It is
possible that transaortic access to the LV
inferior wall provides a greater contact force
and perpendicular catheter tip orientation,
predisposing the myocardium to perforation
during RF [13]. A low tamponade rate in the
subpopulation of patients with VA (0.46%)
could be explained by our practice of careful
RF energy titration led by the impedance drop
of B10 X. Namely, in VA ablation, the decrease
of impedance C18 X was associated with a
significantly more frequent occurrence of
‘‘steam-pop’’ and perforation [8].
Tamponade Management and Outcome
For pericardiocentesis, it is optimal to choose
the shortest and safest route of the needle from
the skin to the pericardium, the direction of the
largest pericardial fluid accumulation and a
technique the operator is most familiar with
[5]. In one study, the echocardiogram-guided
apical approach was predominant (66.7%) [7],
while in another study, the fluoroscopy-guided
subxiphoid approach was mostly used (83.3%)
[8], which is similar to our experience. In our
study, subxiphoid access to the pericardium was
achieved in the left lateral fluoroscopic
projection, which clearly defines the path of
the needle during puncture and best separates
mediastinal, pericardial and myocardial
structures [11]. However, the subxiphoid
access can be complicated by perforation of
the RV, stomach, colon or liver [5, 7, 8]. Indeed,
one of our patients underwent an urgent
surgical abdomen exploration after
pericardiocentesis because of suspected hollow
organ perforation.
Life-saving pericardiocentesis can be
performed via the transcardial approach, by
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the introduction of a long sheath over the
catheter or by a needle through the
myocardium into the pericardial space to
achieve emergency drainage [23]. After fluid
evacuation, it is serially replaced with
angiographic catheters of gradually smaller
lumens until cessation of bleeding or surgical
management [23]. A similar experience in the
present study was noted.
The probability of spontaneous bleeding
cessation after pericardiocentesis depends on
the site, size and geometry of the perforation,
intracavital pressure and anticoagulation level
[5]. Continuous bleeding after pericardiocentesis
requires urgent surgery. Previous studies have
shown that only 13% of patients after atrial
perforation and as much as 55% of patients after
ventricular perforation underwent cardiac
surgery [7, 8]. Similarly, in our study two
(16.7%) patients were surgically treated after
pericardiocentesis. In both cases the LA
perforation caused tamponade. Since the
number of AF ablation procedures is increasing,
the necessity of intra-hospital cardiac surgery
support is becoming an important issue. We
believe that this should be emphasized because
[50% of the centers currently perform AF
ablationswithout in-house surgical back-up [24].
In the present study auto-transfusion was
carried out in seven patients. Direct
auto-transfusion is simple and requires no
additional equipment; it may abolish the need
for allogeneic blood transfusion and can ‘‘buy’’
time until surgery [23]. However, direct
auto-transfusion may cause systemic
inflammation, and therefore the processing of
the drained blood via the cell salvage system is
recommended prior to its return [25].
Auto-transfusion of a larger volume of blood,
i.e., more than 1500 ml, may lead to
consumptive coagulopathy [23, 25], which
occurred in one patient in our study. In such
circumstances, a timely replacement of
coagulation factors and thrombocytes, an
infusion of freshly frozen plasma or a
whole-blood transfusion is necessary [23, 25].
In half of our patients with tamponade, the
planned ablation set of lesions was completed
despite perforation. In case of a smaller
perforation, slow pericardial blood
accumulation left sufficient time for the
ablation to be completed before the
development of tamponade; in another
patient, a larger laceration led to massive
hemorrhage and a sudden collapse soon after
final ‘‘successful’’ RF application. Our study has
also confirmed that ablation can be safely
repeated after 4–8 months and, despite serious
complications, in two-thirds of the patients it
was possible to finally achieve arrhythmia
elimination [7].
Limitations
This study included a 5-year period, and the
learning curve of individual operators might
have significantly influenced the rate of
complications. In addition, the mechanism
and site of perforation in un-operated patients
were determined indirectly. In our study, ICE
and TEE were used in only 7.7% of transseptal
procedures. It is possible that the routine use of
ICE or TEE during the AF ablation procedure
could significantly reduce the rates of cardiac
tamponade and other mechanical
complications. In the current study, AF
ablation was performed with an interrupted
warfarin strategy. Although an uninterrupted
warfarin strategy reduces rates of
thromboembolic stroke and minor bleeding in
this setting, it deviates from the local surgical
practice and has not been implemented in 40%
of low-to-medium volume EP centers in Europe
[26].
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CONCLUSIONS
In our study of a medium-volume center, the
incidence of RF-CA-related cardiac tamponade
was less than 1%, and its occurrence was
significantly associated with AF ablation. The
outcome of tamponade was mostly favorable
after pericardiocentesis, but readily available
cardiothoracic surgery backup was necessary in
one of five to six procedure-related tamponade
cases.
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